Why This Exists
Best Peptide Source is the editorial publication and procurement intelligence resource for the four segments of US clinical decision-makers buying or recommending peptides: 503A and 503B compounding pharmacies, telehealth peptide platforms, peptide therapy and longevity practices, and dermatology and med spa offices. We cover regulatory landscape, supplier diligence, COA verification, pricing intelligence, and the longevity market dynamics from the perspective of the procurement professionals making these decisions.
Best Peptide Source was created to fill that gap: a comprehensive, unbiased resource for B2B peptide procurement that prioritizes transparency, quality verification, and regulatory compliance.
Our Approach
- No pay-for-placement. Supplier listings are based on documented quality standards, not advertising spend.
- Verification first. We evaluate supplier documentation, certifications, and quality practices before listing.
- Regulatory rigor. Our content is built on primary regulatory sources — FDA guidance documents, the FD&C Act, and official agency communications.
- Market intelligence. Our pricing benchmarks and sourcing analysis draw from real supplier interactions and market data.
Editorial Standards
All content on Best Peptide Source is written by industry professionals with direct experience in peptide procurement, pharmaceutical quality assurance, and regulatory compliance. We cite primary sources wherever possible and update content regularly as regulations and market conditions change.
Every article displays its last-updated date. We believe content freshness is a quality signal, and outdated information in a fast-moving regulatory environment is worse than no information at all.
The Editorial Desk
Best Peptide Source is operated by an editorial desk based in Seoul, Republic of Korea. The desk specializes in cross-border pharmaceutical procurement intelligence, with primary coverage of Chinese GMP API supply chains, Korean regulatory frameworks, and US compounding pharmacy procurement. Editorial work is independent and is not subsidized by suppliers, distributors, or platforms covered.
Independence
Best Peptide Source does not accept supplier sponsorships, pay-for-placement, introduction fees, or commissions on supplier transactions. The site does not operate a sourcing service, broker introductions, or facilitate orders between buyers and suppliers. The editorial product is the only product.
Contact
For editorial questions, corrections, or press:
- Editorial: editor@bestpeptidesource.com
- General inquiries: info@bestpeptidesource.com